0 items USD 0.00Search
- Did you mean
- veinsight reminder drug insight200
Your search for "delveinsight remicade drug insights2014" gave back 461088 results.
The global Biosimilar of Remicade market size was valued at US$ 292500 million in 2023. With growing demand in downstream market, the Biosimilar of...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Remicade Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Remicade Biosimilar is...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Remicade (Infliximab) and Biosimilar market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Remicade (Infliximab) Monoclonal Antibody market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Biologic Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of %...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Remicade (Infliximab) and Biosimilar market size was valued at USD 2623.8 million in 2022 and is forecast to a readjusted size of USD 3781...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Remicade (Infliximab) Monoclonal Antibody market size was valued at USD 2623.8 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. The global Tumor Necrosis Factor Inhibitor Drug...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
A Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. The global Tumor Necrosis Factor Inhibitor Drug...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Tumor Necrosis Factor Inhibitors Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Anti-inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions such as treat...
Catalog:
LPI
June 2024
Price: USD 3,660.00
